Posted inTechnology

Pfizer revives weight-loss drug

Pfizer (PFE.N) plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice- daily version of the drug late last year. The new drug is part of the second generation of weight-loss pills under development by companies including Eli […]

Gift this article